Cleveland Clinic Appoints D. Geoffrey Vince, Ph.D., Executive Director of Cleveland Clinic Innovations

Media Contact

Cleveland Clinic News Service 216.444.0141

Cleveland Clinic has named D. Geoffrey Vince, Ph.D., as Executive Director of Cleveland Clinic Innovations.

D. Geoffrey Vince, Ph.D.

In this newly formed role, Dr. Vince will align Cleveland Clinic’s technology development strategies with scientific and research priorities – including unprecedented growth in data and computing sciences – to accelerate the discoveries of new treatments and drugs. He will build strategic partnerships and alliances in these areas to drive revenue growth through commercialization of intellectual property.

“Dr. Vince’s appointment to the helm of Cleveland Clinic Innovations is a key part of our new global strategy for research and innovations,” said Serpil Erzurum, M.D., Cleveland Clinic’s Chief Research and Academic Officer. “His visionary leadership style and wealth of experience in healthcare and industry make him the ideal person to lead Cleveland Clinic Innovations and its critical work to market the breakthrough inventions of our caregivers into new medical products and companies that benefit our patients.”

Dr. Vince has vast experience as a researcher, inventor and leader in both academia and industry, coupling expertise in biomedical engineering research with broad understanding of business practices and goals. His virtual histology technology was licensed by Volcano Corp., which later sold to Philips.

Dr. Vince has been chair of the Department of Biomedical Engineering in the Lerner Research Institute for 10 years. He was principal investigator on Cleveland Clinic’s National Center for Accelerated Innovations and holds 12 patents and several U.S. Department of Defense grants for his research laboratory.

Dr. Vince’s areas of research interest include vascular imaging, image and signal processing and atherosclerotic plaque characteristics, which are pertinent to heart disease and stroke. His team is developing mathematical algorithms based on quantitative ultrasound and acoustic radiation force impulse imaging that can more precisely analyze ultrasound images of carotid arteries. In 2020, he was the recipient of Cleveland Clinic’s Hickey Innovation Impact award for his concept of a “breathalyzer” for rapid COVID-19 diagnosis.

Innovations, the commercial arm of Cleveland Clinic, turns medical breakthrough inventions into patient-benefiting medical products and companies using a unique approach to assess, protect, build, test and market the most promising ideas of Cleveland Clinic caregivers. Founded in 2000, Cleveland Clinic Innovations has helped launch more than 80 start-up companies.

“Cleveland Clinic has an extraordinarily innovative culture, in which all caregivers are encouraged to develop new ideas to improve patient care,” said Dr. Vince. “Cleveland Clinic Innovations serves to facilitate those inventions with the most promise for fueling medical advances and economic growth in Northeast Ohio. We look forward to continuing this tradition while implementing new business strategies.”

Dr. Vince holds the Virginia Lois Kennedy Chair of Biomedical Engineering at Cleveland Clinic and is active in philanthropic endeavors and partnerships with international universities. Originally from northern England, Dr. Vince earned his undergraduate degree in medical sciences and chemistry at DeMontford University in Leicester, England, and began his research career at the University of Liverpool, where he earned his Ph.D. in biomedical engineering.

About Cleveland Clinic
Cleveland Clinic – now in its centennial year – is a nonprofit multispecialty academic medical center that integrates clinical and hospital care with research and education. Located in Cleveland, Ohio, it was founded in 1921 by four renowned physicians with a vision of providing outstanding patient care based upon the principles of cooperation, compassion and innovation. Cleveland Clinic has pioneered many medical breakthroughs, including coronary artery bypass surgery and the first face transplant in the United States. U.S. News & World Report consistently names Cleveland Clinic as one of the nation’s best hospitals in its annual “America’s Best Hospitals” survey. Among Cleveland Clinic’s 70,800 employees worldwide are more than 4,660 salaried physicians and researchers, and 18,500 registered nurses and advanced practice providers, representing 140 medical specialties and subspecialties. Cleveland Clinic is a 6,500-bed health system that includes a 173-acre main campus near downtown Cleveland, 19 hospitals, more than 220 outpatient facilities, and locations in southeast Florida; Las Vegas, Nevada; Toronto, Canada; Abu Dhabi, UAE; and London, England. In 2020, there were 8.7 million total outpatient visits, 273,000 hospital admissions and observations, and 217,000 surgical cases throughout Cleveland Clinic’s health system. Patients came for treatment from every state and 185 countries. Visit us at clevelandclinic.org. Follow us at twitter.com/ClevelandClinic. News and resources available at newsroom.clevelandclinic.org.

Editor’s Note: Cleveland Clinic News Service is available to provide broadcast-quality interviews and B-roll upon request.